110 related articles for article (PubMed ID: 1576722)
41. Inhibition of tumor promoter 12-O-tetradecanoylphorbol-13-acetate-induced synthesis of epidermal ornithine decarboxylase messenger RNA and diacylglycerol-promoted mouse skin tumor formation by retinoic acid.
Verma AK
Cancer Res; 1988 Apr; 48(8):2168-73. PubMed ID: 3349487
[TBL] [Abstract][Full Text] [Related]
42. [Inhibition of ornithine decarboxylase activity and epidermal papilloma in mice by beta-carotene].
Tan A; Wu K; Huang M
Zhonghua Yu Fang Yi Xue Za Zhi; 1995 Nov; 29(6):360-2. PubMed ID: 8697943
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-mediated epidermal ornithine decarboxylase induction and skin tumor promotion by new lipoxygenase inhibitors lacking protein kinase C inhibitory effects.
Aizu E; Nakadate T; Yamamoto S; Kato R
Carcinogenesis; 1986 Nov; 7(11):1809-12. PubMed ID: 3094975
[TBL] [Abstract][Full Text] [Related]
44. Local anesthetics inhibit induction of ornithine decarboxylase by the tumor promoter 12-O-tetradecanoylphorbol 13-acetate.
Yuspa SH; Lichti U; Ben T
Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5312-6. PubMed ID: 6933562
[TBL] [Abstract][Full Text] [Related]
45. Effect of dietary arginine restriction upon ornithine and polyamine metabolism during two-stage epidermal carcinogenesis in the mouse.
Gonzalez GG; Byus CV
Cancer Res; 1991 Jun; 51(11):2932-9. PubMed ID: 1903327
[TBL] [Abstract][Full Text] [Related]
46. Correlation of phorbol ester promotion in the resistant C57BL/6J mouse with sustained hyperplasia but not ornithine decarboxylase or protein kinase C.
Fischer SM; Jasheway DW; Klann RC; Butler AP; Patrick KE; Baldwin JK; Cameron GS
Cancer Res; 1989 Dec; 49(23):6693-9. PubMed ID: 2819717
[TBL] [Abstract][Full Text] [Related]
47. Targeted antizyme expression in the skin of transgenic mice reduces tumor promoter induction of ornithine decarboxylase and decreases sensitivity to chemical carcinogenesis.
Feith DJ; Shantz LM; Pegg AE
Cancer Res; 2001 Aug; 61(16):6073-81. PubMed ID: 11507056
[TBL] [Abstract][Full Text] [Related]
48. Tumor promoter-induced refractory state against ornithine decarboxylase induction by 12-O-tetradecanoylphorbol-13-acetate in mouse epidermis.
Takigawa M; Simsiman RC; Boutwell RK
Cancer Res; 1986 Jan; 46(1):106-12. PubMed ID: 3940182
[TBL] [Abstract][Full Text] [Related]
49. Tumor prevention by a xanthate compound in experimental mouse-skin tumorigenesis.
Fürstenberger G; Amtmann E; Marks F; Sauer G
Int J Cancer; 1989 Mar; 43(3):508-12. PubMed ID: 2494119
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and epidermal ornithine decarboxylase activity in mouse skin by palmitoylcarnitine.
Nakadate T; Yamamoto S; Aizu E; Kato R
Cancer Res; 1986 Apr; 46(4 Pt 1):1589-93. PubMed ID: 3081251
[TBL] [Abstract][Full Text] [Related]
51. A course of very small doses of DMBA, each of them allegedly with no promoting potency, acts with clear synergistic effect as a strong promoter of DMBA-initiated mouse skin carcinogenesis. A comparison of the tumorigenic and carcinogenic effects of DMBA (7,12-dimethylbenz-alpha-anthracene) and TPA (12-O-tetradecanoyl-phorbol-13-acetate) used as initiators and promoters in classical two-stage experimental protocols.
Iversen OH
APMIS Suppl; 1994; 41():1-38. PubMed ID: 7946481
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papilloma by saponins.
Tokuda H; Konoshima T; Kozuka M; Kimura T
Oncology; 1991; 48(1):77-80. PubMed ID: 1846234
[TBL] [Abstract][Full Text] [Related]
53. Dissociation of increases in levels of 3':5'-cyclic AMP and 3':5'-cyclic GMP from induction of ornithine decarboxylase by the tumor promoter 12-O-tetradecanoyl phorbol-13-acetate in mouse epidermis in vivo.
Mufson RA; Astrup EG; Simsiman RC; Boutwell RK
Proc Natl Acad Sci U S A; 1977 Feb; 74(2):657-61. PubMed ID: 191821
[TBL] [Abstract][Full Text] [Related]
54. Potent suppressive activity of nonpolyphenolic fraction of green tea (Camellia sinensis) against genotoxin-induced umu C gene expression in Salmonella typhimurium (TA 1535/pSK 1002), tumor promotor-dependent ornithine decarboxylase induction of BALB/c 3T3 fibroblast cells, and chemically induced mouse skin tumorigenesis.
Okai Y; Higashi-Okai K
Teratog Carcinog Mutagen; 1997-1998; 17(6):305-12. PubMed ID: 9485539
[TBL] [Abstract][Full Text] [Related]
55. Mechanism of mouse skin tumor promotion by chrysarobin.
DiGiovanni J; Decina PC; Prichett WP; Cantor J; Aalfs KK; Coombs MM
Cancer Res; 1985 Jun; 45(6):2584-9. PubMed ID: 3986797
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid.
Huang MT; Ho CT; Wang ZY; Ferraro T; Lou YR; Stauber K; Ma W; Georgiadis C; Laskin JD; Conney AH
Cancer Res; 1994 Feb; 54(3):701-8. PubMed ID: 8306331
[TBL] [Abstract][Full Text] [Related]
57. Salix caprea inhibits skin carcinogenesis in murine skin: inhibition of oxidative stress, ornithine decarboxylase activity and DNA synthesis.
Sultana S; Saleem M
J Ethnopharmacol; 2004 Apr; 91(2-3):267-76. PubMed ID: 15120450
[TBL] [Abstract][Full Text] [Related]
58. (-)-Epigallocatechin-3-gallate in Camellia sinensis leaves from Himalayan region of Sikkim: inhibitory effects against biochemical events and tumor initiation in Sencar mouse skin.
Katiyar SK; Agarwal R; Wang ZY; Bhatia AK; Mukhtar H
Nutr Cancer; 1992; 18(1):73-83. PubMed ID: 1408948
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of tumor promotion in mouse skin by 1 alpha,25-dihydroxyvitamin D3.
Chida K; Hashiba H; Fukushima M; Suda T; Kuroki T
Cancer Res; 1985 Nov; 45(11 Pt 1):5426-30. PubMed ID: 3840412
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-caused tumor promotion in benzo[a]pyrene-initiated CD-1 mouse skin by geniposide.
Lee MJ; Hsu JD; Wang CJ
Anticancer Res; 1995; 15(2):411-6. PubMed ID: 7763014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
